Ovarian cancer: experts call for genetic screening

| | June 25, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Women with nonmucinous ovarian cancer should be routinely screened for BRCA1/2 mutations, say the Australian authors of groundbreaking research which shows patients with the mutation respond better to treatment than non-carriers.

View the original article here: Ovarian cancer: experts call for genetic screening – Oncology Update

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend